TGFB1 and neoplasm: However, Tregs, characterized by FOXP3 and CD25 expression, suppress anti-tumor responses through both cytokine-dependent (e.g., IL-10, TGF-β, IL-35) and contact-mediated mechanisms, dampening the activity of effector T cells, dendritic cells, and NK cells [98, 123].